Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Islet & Pancreas Transplant Archives
Print | Email | Share | Comments (0)

Micro- and Macroencapsulation: Firms Try Different Approaches to Protect Islets


Aug 1, 1999

Just as islet research is developing at the university level, corporations are taking steps toward creating devices and technologies to aid islet transplantation.

One such company is VivoRx, founded by Patrick Soon Shiong, MD, who reports that VivoRx is making strides in technology to proliferate islets and to encapsulate them.

Proliferating islets is necessary for islet transplantation. Currently, not enough donor pancreases exist, making it difficult to obtain enough islets to transplant into all those who would benefit from an islet transplant. Proliferation involves reproducing human islets, so you can start with just one islet, but make enough for a successful transplant.

ViviRx is pursuing this technology, having abandoned its attempts to transplant porcine (pig) islets into humans.

"We made a decision, based on scientific and safety issues, to go back to human islets," says Soon Shiong, citing the identification of viruses from pig islets as a potential danger.

In proliferating human islets, Soon Shiong and his team have identified "progenitor cells," which are "not exactly" stem cells, but "early cells" that can be manipulated to secrete insulin.

"This work is still preliminary," reports Soon Shiong.

Microencapsulation

VivoRx also has microencapsulation technology, the goal of which is to protect transplanted islets from the body's immune system. Islets are placed in VivoRx's own capsule technology, where the hope is they will be protected without the need for immunosuppressive drugs. Soon Shiong's team will begin clinical trials on type 1 humans without immunosuppression.

Macroencapsulation: Islet Sheet Medical

Islet Sheet Medical, started by type 1 Scott R. King, is working on a different method of protecting islets. It is called macroencapsulation. Instead of encapsulating each islet individually (called microencapsulation), it encapsulates many islets, up to about 160,000, to be exact. It's done with the company's namesake, an islet sheet.

But, what is an islet sheet? According to King, "It's like a really big contact lens." Like other encapsulation devices, it has to keep the body's immune attack forces out, allow in substances necessary to keep the islets working, and let out insulin. King says the sheet has proven it can do all of this in dogs, and he looks forward to beginning more trials.


Categories: Insulin, Islet & Pancreas Transplant



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Aug 1, 1999

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.